Novo Nordisk
NVO
#14
Rank
$572.92 B
Marketcap
$128.40
Share price
0.27%
Change (1 day)
65.34%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - P/B ratio

P/B ratio as of March 2024 : 36.3

According to Novo Nordisk's latest financial reports the company has a price-to-book ratio of 36.3.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novo Nordisk - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-3129.215.38%
2022-12-3125.36.95%
2021-12-3123.752.01%
2020-12-3115.6-3.3%
2019-12-3116.114.45%
2018-12-3114.1-13.79%
2017-12-3116.311.13%
2016-12-3114.7-33.6%
2015-12-3122.129.3%
2014-12-3117.133.29%
2013-12-3112.81.69%
2012-12-3112.623.48%
2011-12-3110.2-0.13%
2010-12-3110.274.1%
2009-12-315.8812.05%
2008-12-315.25-21.13%
2007-12-316.6533.99%
2006-12-314.9719.09%
2005-12-314.1712.43%
2004-12-313.7112.2%
2003-12-313.319.33%
2002-12-313.02

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
1.76-95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
68.1 87.55%๐Ÿ‡บ๐Ÿ‡ธ USA
1.48-95.93%๐Ÿ‡ซ๐Ÿ‡ท France
3.72-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA